Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Nathanson+Hauck

2. Address

Address1
601 13th Street NW
 Address2
​Suite 290 North
City
Washington
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Melanie Nathanson
​2022589381
​mnathanson@n-hdc.com
5. Senate ID#
​400693064-140
7. Client Name Self Check if client is a state or local government or instrumentality
​Blue Cross Blue Shield of Massachusetts
6. House ID#
​415240013
TYPE OF REPORT 8. Year
​2024
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​60,000.00
$5,000 or more $
​
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Melanie Nathanson
 Date
12/29/2024 10:54:42 AM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage.

CMS Rules and Regulations focused on the promulgation of the Medicare Wage Index.

Issues related to Medicare Advantage stars and other quality ratings.

H.R 7623 - Telehealth Modernization Act of 2024 - Support for extension of Covid-era telemedicine provisions.

Support for extension of ACA APTCs to support affordable coverage in the SBM and FFM insurance marketplaces.

H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access.

H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.

H.R. 7024 - Tax Relief for American Families and Workers Act of 2024. - Support for the expansion of the current child tax credit and other policies.

S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.

S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports

Issues related to making over-the-counter Naloxone accessible and available.

Issues related to improving mental health care access for plan members and Medicare beneficiaries.

Rules, Regulations and legislative policies related to the Medicare Advantage program.

Issues related to identifying and addressing social determinants of health.

Issues related to the insurance Marketplace and providing full and affordable coverage options.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Melanie
Nathanson
​
​
Megan
Hauck
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for administering programs that support Medicare and Marketplace health care coverage.

CMS Rules and Regulations focused on the promulgation of the Medicare Wage Index.

H.R 7623 - Telehealth Modernization Act of 2024 - Support for extension of Covid-era telemedicine provisions.

Support for extension of ACA APTCs to support affordable coverage in the SBM and FFM insurance marketplaces.

H.R. 4366 - Consolidated Appropriations Act, 2024 - Issues related to health care extenders and other policies focused on coverage and access in the Medicare, Medicaid and Marketplaces.

H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to the funding of the Department of Health and Human Services and its agencies.


S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.

S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports

Issues related to improving mental health care access for plan members and Medicare beneficiaries.

Rules, Regulations and legislative policies related to the Medicare Advantage program.

Issues related to identifying and addressing social determinants of health and equity.

Issues related to the insurance Marketplace and providing full and affordable coverage options.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Megan
Hauck
​
​
Melanie
Nathanson
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)